A Study of Pazopanib With CAPEOX in AGC Patients
NCT01130805
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
66
Enrollment
OTHER
Sponsor class
Conditions
Gastric Cancer
Interventions
DRUG:
Pazopanib in combination with capecitabine and oxaliplatin
Sponsor
Samsung Medical Center